Elizabeth Masson-Hurlburt

Chief Operating Officer at CORMEDIX INC.

Net worth: 2 M $ as of 2026-05-30

47 year

Health Technology

Consumer Services

Profile

Elizabeth Masson-Hurlburt is currently EVP, Chief Operating & Integration Officer at CorMedix, Inc., a position starting in 2025.
Formerly, Ms. Masson-Hurlburt was Vice President-Clinical Operations at Gemphire Therapeutics, Inc. from 2016 to 2018.
Education includes undergraduate studies at Bay Path College and graduate studies at Western Governors University.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
CORMEDIX INC. 0.36%	2026-02-03	278,539 ( 0.36% )	2 M $	2026-05-30

Elizabeth Masson-Hurlburt active positions

Companies	Position	Start
CORMEDIX INC.	Chief Operating Officer	-

All active positions of Elizabeth Masson-Hurlburt

Former positions of Elizabeth Masson-Hurlburt

Companies	Position	End
METAVIA INC.	Chief Tech/Sci/R&D Officer	2018-02-28

See the detail of Elizabeth Masson-Hurlburt's experience

Training of Elizabeth Masson-Hurlburt

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Elizabeth Masson-Hurlburt's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
CorMedix, Inc. CorMedix, Inc. BiotechnologyHealth Technology Develops medical devices for cardiovascular and kidney diseases	Health Technology
Bay Path College Bay Path College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Western Governors University Western Governors University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Gemphire Therapeutics, Inc. Gemphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies for the treatment of Dyslipidemia	Health Technology